Hyperforin, an acylphloroglucinol derivative, is a major constituent of St. John’s
wort extract (Hypericum
perforatum L.), which is used in treating depressive disorders. Hyperforin has been demonstrated
as a modulator of several neuronal ion channels, and inhibits smooth-muscle contraction
induced by various neurotransmitters. To evaluate the spasmolytic properties of hyperforin
in more detail, we performed studies on the hamster vas deferens smooth muscle cell
line DDT1-MF2. In a first series of experiments, we determined the effect of hyperforin on
intracellular Ca2+ concentration ([Ca2+]i) using the fluorochrome fura-2. These investigations were supplemented in a second
series of assays, where the effects on cellular metabolism were analysed by measuring
the rate of extracellular release of acidic metabolites with the help of a microphysiometer.
Hyperforin (0.3 - 10 µg/ml) caused a concentration-dependent elevation of [Ca2+]i and extracellular acidification rate (ECAR). Both of these effects were independent
of extracellular Ca2+. To elucidate whether the increase of [Ca2+]i by hyperforin causes or results from its ECAR-stimulating properties, we used various
pharmacological tools to reveal the sequence of events and the molecular mechanisms
involved. Our results suggest that hyperforin induces release of Ca2+ from as yet unidentified sources. Since the ECAR stimulation was inhibited to a different
extent by the intracellular Ca2+ chelator BAPTA as well as by inhibitors of plasmalemmal and mitochondrial Na+/Ca+ exchange, but not by inhibitors of Na+/H+ antiport, the intracellular Ca2+ increase seems to be essential for this hyperforin effect. However, further studies
are needed to establish the exact mode of action, and to deduce whether this aspect
of hyperforin activity contributes to its antidepressant and neuroprotective effects.
References
- 1
Bhattacharya S K, Chakrabarti A, Chatterjee S S.
Activity profiles of two hyperforin-containing hypericum extracts in behavioral models.
Pharmacopsychiatry.
1998;
31
((Suppl. 1))
22-29
- 2
Chatterjee S S, Bhattacharya S K, Wonnemann M, Singer A, Müller W E.
Hyperforin as a possible antidepressant component of hypericum extracts.
Life Sci.
1998;
63
499-510
- 3
Chatterjee S S, Filippov V, Lishko P, Maximyuk O, Nöldner M, Krishtal O.
Hyperforin attenuates various ionic conductance mechanisms in the isolated hippocampal
neurons of rat.
Life Sci.
1999;
65
2395-2405
- 4
Chatterjee S S, Nöldner M, Koch E, Erdelmeier C.
Antidepressant activity of hypericum perforatum and hyperforin: the neglected possibility.
Pharmacopsychiatry.
1998;
31
((Suppl. 1))
7-15
- 5
Egger M, Niggli E.
Regulatory function of Na-Ca exchange in the heart: milestones and outlook.
J Membr Biol.
1999;
168
107-130
- 6
Kaehler S T, Sinner C, Chatterjee S S, Philippu A.
Hyperforin enhances the extracellular concentrations of catecholamines, serotonin
and glutamate in the rat locus coeruleus.
Neurosci Lett.
1999;
262
199-202
- 7
Kobayashi Y, Pang T, Iwamoto T, Wakabayashi S, Shigekawa M.
Lithium activates mammalian Na+/H+ exchangers: isoform specificity and inhibition by genistein.
Pflügers Arch - Eur J Physiol.
2000;
439
455-462
- 8
Laakmann G, Schule C, Baghai T, Kieser M.
St. John’s wort in mild to moderate depression: the relevance of hyperforin for the
clinical efficacy.
Pharmacopsychiatry.
1998;
31
((Suppl. 1))
54-59
- 9
McConnell H M, Owicki J C, Parce J W, Miller D L, Baxter G T, Wada H G. et al .
The cytosensor microphysiometer: biological applications of silicon technology.
Science.
1992;
257
1906-1912
- 10
Müller W E, Singer A, Wonnemann M, Hafner U, Rolli M, Schäfer C.
Hyperforin represents the neurotransmitter reuptake inhibiting constituent of hypericum
extract.
Pharmacopsychiatry.
1998;
31
((Suppl. 1))
16-21
- 11
Orlowski J, Ginstein S.
Na+/H+ exchangers of mammalian cells.
J Biol Chem.
1997;
273
22 373-22 376
- 12
Singer A, Wonnemann M, Müller W E.
Hyperforin, a major antidepressant constituent of St. John’s Wort, inhibits serotonin
uptake by elevating free intracellular Na+.
.
J Pharmacol Exp Therap.
1999;
290
1363-1368
Dr. E. Koch
Department of Pharmacology
Dr. Willmar Schwabe GmbH & Co., Arzneimittel
Dr. Willmar-Schwabe-Straße 4
76227 Karlsruhe
Germany